Abstract submission for our next annual congress is now open! EAN Programme Committee Chair, Prof. Ulf Kallweit shares the details on this and other latest news about EAN 2023.
-
-
Paper of the MonthEAN NewsFeatured SliderResearch Paper of the Month: Lecanemab in Early Alzheimer’s Disease
Our authors of the month report the results of a multicentre phase-3 clinical trial exploring efficacy and safety of Lecanemab in patients with early AD over a follow-up period of eighteen months. -
Paper of the MonthEAN NewsCOVID-19Featured SliderCovid-19 Paper of the Month: Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis
Our authors of the month conducted a retrospective study of the potential association between COVID-19 and seizures or epilepsy in the six months after infection, using an electronic health records network of 81 million people. -
EAN NewsResearchIncreasing transparency: publication of the development and launch process for the EAN guideline prioritisation procedure
A new publication in the European Journal of Neurology describes the process of developing and launching the EAN guideline prioritisation procedure. -
EAN Guideline production group (GPG) reports from this year's Guidelines International Network conference in Toronto. -
The EAN was delighted to welcome 54 participants from 24 countries to Loutraki, Greece, for three days of sea, sunshine and neurology at our 2022 Autumn School. -
This call is to find a suitable candidate for the position of EAN Website Editor -
EAN NewsBreaking newsCOVID-19COVID-19 Breaking News: Meta-analyses/systematic reviews – November 2022
Our highlighted selection of COVID-19-related meta-analyses and systemic reviews from the scientific press for November 2022. *Note – starting in December 2022 our monthly COVID-19 Breaking News articles will be published under the new name ‘Covid Research Roundup’* -
EAN NewsBreaking newsCOVID-19COVID-19 Breaking News: Cross-Sectional Case Control Studies – November 2022
Our pick of COVID-19-related cross-sectional case control studies from the scientific press for November 2022. *Note – starting in December 2022 our monthly COVID-19 Breaking News articles will be published under the new name ‘Covid Research Roundup’* -
Call for expression of interest: EAN representative on the Joint Education Board (EAN & UEMS-SN/EBN) -
Our selection of miscellaneous COVID-19-related studies from the scientific press for November 2022. *Note – starting in December 2022 our monthly COVID-19 Breaking News articles will be published under the new name ‘Covid Research Roundup’* -
EAN NewsBreaking newsCOVID-19COVID-19 Breaking News: Observational Studies – Prospective Longitudinal Cohort – November 2022
Our editors' pick of COVID-19-related observational studies from the scientific press for November 2022. *Note - starting in December 2022 our monthly COVID-19 Breaking News articles will be published under the new name 'Covid Research Roundup'* -
Executive PageEAN NewsFeatured SliderExecutive Page: New guideline prioritisation process begins setting path for next two years
EAN Scientific Committee Chair, Prof. Thomas Berger, provides a general update, including guideline prioritisation news, ongoing research projects and the forthcoming 2nd EAN Science School. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion
Our research paper of the month presents the results of the Endovascular Treatment for Acute Basilar-Artery Occlusion (ATTENTION) trial; a multicentre, prospective, randomised and open-label trial, conducted in 36 Chinese centres. -
Paper of the MonthEAN NewsCOVID-19Featured Slider
Covid-19 Paper of the Month: Post-acute sequelae of covid-19 six to twelve months after infection
The authors of our Covid paper of the month conducted this cross sectional study in southern Germany involving people aged 18–65, confirming the existence of a considerable burden of self-reported post-acute symptom clusters